Inpatient Blood Glucose Control in Taichung Veterans General Hospital

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

Also called NCT02885909

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Taichung Veterans General Hospital (from the registry)
Registry
  • NCT NCT02885909
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02885909. Non-randomized; no masking; primary purpose treatment. Start 2016-09 (registry gives no type); primary completion 2022-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Inpatient Blood Glucose Control in Taichung Veterans General Hospital
Condition
HYPERGLYCEMIA
Intervention (Device)
CONTINUE GLUCOSE MONITOR
Intervention (Procedure)
Insulin protocal
Lead sponsor
Taichung Veterans General Hospital (class: other)

Record details

Record id
cardio:ct-nct02885909
Content hash
304ac996decf5ecbab48236a42e31496727ba4877f6e9cd0eeb8c7b3df669a1f